Bright Minds BiosciencesDRUG
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 34 institutions reported holding Bright Minds Biosciences Inc. (DRUG) in their 13F filings, up 3 from Q4 2024. 10 opened new positions and 7 sold out. The largest holders were Janus Henderson Group PLC ($40.3M), Cormorant Asset Management, LP ($38.2M) and Sio Capital Management, LLC ($18.3M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Bright Minds Biosciences Inc.
- CUSIP
- 10919W405
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $4.0M |
| Exits | 7 | $11.6M |
All 13F filers, Q4 2024 → Q1 2025: 1,046,950 shares bought and 726,583 shares sold, net +320,367 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Janus Henderson Group PLC | 0.02% | Add +118.4% | 1,111,368 | $40.3M |
| Cormorant Asset Management, LP | 2.89% | No change | 1,059,331 | $38.2M |
| Sio Capital Management, LLC | 5.54% | Add +12.3% | 507,562 | $18.3M |
| Commodore Capital LP | 1.33% | No change | 500,000 | $18.0M |
| Perceptive Advisors LLC | 0.57% | Add +10.2% | 444,649 | $16.0M |
| Vivo Capital, LLC | 1.20% | No change | 251,572 | $9.1M |
| Ra Capital Management, L.P. | 0.12% | Reduce -55.2% | 206,427 | $7.4M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | Add +50.9% | 200,000 | $7.2M |
| Millennium Management | 0.01% | Add +376.9% | 192,557 | $6.9M |
| Morgan Stanley | 0.00% | Reduce -6.6% | 156,550 | $5.6M |
| Point72 Asset Management | 0.01% | Reduce -0.1% | 135,020 | $4.9M |
| Walleye Capital LLC | 0.04% | Reduce -17.6% | 85,022 | $3.1M |
| Schonfeld Strategic Advisors LLC | 0.02% | Add +8.3% | 75,601 | $2.7M |
| Ikarian Capital, LLC | 0.77% | Reduce -57.0% | 65,431 | $2.4M |
| Acuta Capital Partners, LLC | 2.50% | Reduce -13.6% | 59,748 | $2.2M |
| Platinum Investment Management Ltd. | 0.06% | New | 28,308 | $1.0M |
| Goldman Sachs Group Inc. | 0.00% | New | 22,222 | $802K |
| Boothbay Fund Management, LLC | 0.03% | Reduce -57.0% | 19,164 | $691K |
| Marshall Wace, LLP | 0.00% | New | 18,756 | $677K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 14,000 | $505K |
| HRT Financial LP | 0.00% | New | 13,568 | $489K |
| UBS Group AG | 0.00% | Add +13.5% | 11,535 | $416K |
| AdvisorShares Investments LLC | 0.08% | Add +266.9% | 11,281 | $407K |
| Citadel Advisors | 0.00% | New | 6,885 | $248K |
| Jane Street Group, LLC | 0.00% | No change | 6,600 | $238K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.01% | New | 5,963 | $215K |
| Bank of America Corp. | 0.00% | Add +13.0% | 5,416 | $195K |
| BNP Paribas Financial Markets | 0.00% | New | 1,100 | $40K |
| BlackRock, Inc. | 0.00% | Add +67700.0% | 678 | $24K |
| Royal Bank of Canada | 0.00% | Reduce -28.0% | 589 | $21K |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 140 | $5K |
| JPMorgan Chase & Co. | 0.00% | New | 300 | $2K |
| SBI Securities Co., Ltd. | 0.00% | No change | 55 | $2K |
| Citigroup Inc. | 0.00% | No change | 1 | $36 |
"% of holder's portfolio" is DRUG's weight in each manager's 13F, not the share of Bright Minds Biosciences Inc. the manager owns.